$ Value
$0
Shares
41,200
Price
$0
Filed
Jun 24
Insider
Name
BERGER FRANKLIN M
Title
—
CIK
0001273885
Roles
Transaction Details
Transaction Date
2025-06-20
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
41,200
Footnotes
Restricted stock units convert into common stock on a one-for-one basis. | The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. | The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. | The restricted stock units vested in full on June 20, 2025.
Filing Info
BERGER FRANKLIN M's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-09 | EPIX | D | — |
| 2025-06-20 | AVIR | M | $0 |
| 2025-06-20 | AVIR | A | $0 |
| 2025-06-20 | AVIR | A | $0 |
| 2025-06-20 | AVIR | M | $0 |
| 2025-06-18 | KZR | A | $0 |
Other Insiders at AVIR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sommadossi Jean-Pierre
President, CEO, and Chairman
|
— | — | 2026-02-03 |
|
Corcoran Andrea
See Remarks
|
— | — | 2026-03-11 |
|
Foster Wayne
EVP, Chief Accounting Officer
|
— | — | 2026-01-31 |
|
Horga Maria Arantxa
Chief Medical Officer
|
— | — | 2026-01-31 |
|
Vavricka John
Chief Commercial Officer
|
— | — | 2026-01-31 |
|
Hammond Janet MJ
Chief Development Officer
|
— | — | 2026-01-31 |